NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-179-2018-0-US-01 Remodelins, A New Class Of Compounds To Prevent Or Treat Cancer Metastasis Or Glaucoma US 62/828,122 Abandoned
NIBIB E-225-2014-0-US-05 Resolution Enhancement With Line Scanning Excitation US CON 16/371,641 11106027 Abandoned PDF
NIAID E-228-2016-1-KR-10 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof KR National Stage 10-2019-7009334 Abandoned
NIBIB E-005-2012-3-FR-01 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS FR EP 18814333.3 Issued
NIBIB E-005-2012-3-DE-01 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS DE EP 18814333.3 Issued
NIBIB E-005-2012-3-IE-01 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS IE EP 18814333.3 Issued
NIBIB E-005-2012-3-CH-01 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS CH EP 18814333.3 Issued
NIBIB E-005-2012-3-GB-01 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS GB EP 18814333.3 Issued
NIBIB E-005-2012-3-EP-09 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS EP National Stage 18814333.3 Issued
NCI E-269-2010-0-EP-14 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE EP DIV 19166061.2 Issued
NCI E-269-2010-0-GB-33 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE GB EP 19166061.2 Issued
NCI E-269-2010-0-CH-29 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CH EP 19166061.2 Issued
NCI E-269-2010-0-ES-31 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE ES EP 19166061.2 Issued
NCI E-269-2010-0-NL-36 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE NL EP 19166061.2 Issued
NCI E-269-2010-0-PT-37 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PT EP 19166061.2 Issued
NCI E-269-2010-0-IT-35 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IT EP 19166061.2 Issued
NCI E-269-2010-0-AT-27 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE AT EP 19166061.2 Issued
NCI E-269-2010-0-BE-28 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE BE EP 19166061.2 Issued
NCI E-269-2010-0-DE-30 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE DE EP 19166061.2 Issued
NCI E-269-2010-0-IE-34 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IE EP 19166061.2 Issued
NCI E-269-2010-0-FR-32 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE FR EP 19166061.2 Issued
NCI E-105-2018-0-PCT-02 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data PCT PCT PCT/US2019/024975 Expired
NCI E-062-2019-3-EP-04 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide EP National Stage 17791484.3 Abandoned
NCI E-105-2018-0-AU-03 BIOMARKER ANALYSIS FOR HIGH-THROUGHPUT DIAGNOSTIC MULTIPLEX DATA AU National Stage 2019245402 Pending
NCI E-077-2017-0-US-02 CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE US DIV 16/367,546 10828364 Issued PDF
NIAID E-076-2015-5-JP-23 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES JP DIV 2019-063057 Abandoned
NCATS E-252-2017-1-US-01 METHOD OF TREATMENT OF CANCER CELLS EXHIBITING TRAIL RESISTANCE US 68/825,397 Abandoned
NCATS E-091-2017-0-US-01 Mounted Nitrocellulose Membrane Plates For Aqueous Acoustic Dispensing Nanoliter-Scale Reverse Phase Protein And Biological Arrays For Antibody-Based Protein Detection And Quantification US 62/825,397 Abandoned
NIAID E-228-2016-1-AU-07 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof AU National Stage 2017321883 Issued
NIAID E-242-2011-0-US-06 Isolation Of Novel Broadly Neutralizing Monoclonal Antibodies Against HIV-1 Using Epitope-specific Glycoprotein Probes To Identify HIV-1 Specific B-cells US DIV 16/366,980 Abandoned
NHLBI E-207-2016-0-US-03 Method To Increase Carboxylic Acid Content On Fluorescent Nanodiamonds US National Stage 16/336,709 10995004 Issued PDF
NCI E-062-2019-3-JP-05 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide JP National Stage 2019-516536 Abandoned
NCI E-062-2019-3-US-08 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US National Stage 16/336,724 Abandoned
NCI E-100-2018-0-PCT-02 ACTIVATORS OF TYPE II NKT CELLS AND METHODS OF USE THEREOF PCT PCT PCT/US2019/023890 Expired
NIAID E-297-2016-2-JP-05 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES JP National Stage 2019-537752 Issued
NCATS E-091-2017-0-US-01_78650 MEMBRANE PLATES FOR HIGH-THROUGHPUT PROTEIN DETECTION AND QUANTIFICATION US 62/822,326 Abandoned
NCATS E-040-2015-0-US-07 Compounds For Niemann Pick C And Other Iysosomal Storage Disorders US CON 16/362,179 Abandoned
NCI E-042-2014-0-US-17 CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US DIV 16/360,281 11236161 Issued PDF
NCI E-280-2016-0-EP-04 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME EP National Stage 17784443.8 Pending
NCI E-062-2019-3-SG-07 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide SG National Stage 11201902532R Abandoned
NCI E-280-2016-0-US-05 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME US National Stage 16/334,872 11976299 Issued PDF
NIAID E-297-2016-2-US-06 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US National Stage 16/335,099 10808012 Issued PDF
NINR E-222-2018-0-PCT-02 INSTRUMENTATION-FREE PAPER ORIGAMI RAPID MOLECULAR DIAGNOSTIC DEVICE PCT PCT PCT/US2019/023234 Expired
NCI E-048-2010-0-US-06 AGONIST / ANTAGONIST COMPOSITIONS AND METHODS OF USE US DIV 16/359,931 Abandoned
NCI E-258-2016-0-US-07 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR
CCR4 AND ITS USE 		US National Stage 16/334,724 11077178 Issued PDF
NCI E-084-2019-0-US-01 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand US 62/820,604 Abandoned
NCI E-264-2011-0-AU-09 Delivery Of Packaged RNA To Mammalian Cells AU DIV 2019201911 Abandoned
NIDA E-017-2018-0-FR-05 BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME FR EP 19714936.2 Issued
NIDA E-017-2018-0-DE-06 BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME DE EP 19714936.2 Issued
NIDA E-017-2018-0-GB-07 BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME GB EP 19714936.2 Issued